Check please! Endocrine Sequela of Immune Check Point Inhibitors
A CSEM Knowledge Transfer Activity (KTA)
Thursday, May 4, 2023 from 7:00-9:00 pm ET
Dr. Rosalyn Juergens, Medical Oncologist, Hamilton, will describe endocrine side effects of immune check point inhibitors, focusing on the diagnosis and treatment of common types of endocrinopathies induced by immune check point inhibitors. Our panel, which includes community and academic endocrinologists, will discuss the pearls and pitfalls in the management of these patients, and how to enhance collaboration between specialties to improve patient care.
This self-assessment program will include pre- and post- tests using live polling during the session to allow you to claim Section 3 credits.
Learning Objectives
At the end of this session, participants will be able to:
- Describe the mechanisms of action of, and identify common indications for immune check point inhibitors
- Recognize and diagnose endocrine complications of immune check point inhibitors
- Manage endocrine complications during and after treatment with immune check point inhibitors
Faculty
Dr. Sabrina Gill, St. Paul's Hospital, Vancouver (KTA Chair, Moderator)
Dr. Rosalyn Juergens, McMaster, Hamilton (Presenter)
Dr. Yuan Kong, Community Endocrinologist, Toronto (Panelist)
Dr. Elizabeth Rosolowsky, University of Alberta, Edmonton (CSEM CPD Chair)
This session is free for CSEM members and $100 for non-members.
If you have not yet renewed your CSEM membership for 2023, please renew now.
CSEM's 2021-2023 Knowledge Transfer Activities were planned independently by CSEM to ensure scientific integrity, objectivity and balance.
In support of our KTAs, CSEM has received unrestricted educational grants from:
Advocate Sponsors
Amgen
Bayer
MD Financial/Scotiabank Healthcare+
Pfizer Rare Diseases
Viatris
Innovator Sponsor
Bristol-Myers Squibb
